pharmaphorum August 15, 2022
Phil Taylor

In draft guidance, NICE has said that AliveCor’s ECG recording device should be an option to check or heart disturbances in patients who take antipsychotic medicines.

The KardiaMobile 6L – first introduced in 2019 – is an update to AliveCor’s earlier ECG with an additional electrode to make it a six-lead device that improves the accuracy of heart rhythm measurements.

Like its predecessor, it links to a smartphone app which includes an artificial intelligence system that can detect for example whether atrial fibrillation, bradycardia (slow heart rhythm), tachycardia (fast heart rhythm) or a normal rhythm is detected.

The draft guidance (PDF) cover use of the device and app for people taking antipsychotics, who need to be tested before and...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Digital Health, Medical Devices, Patient / Consumer, Provider, Technology
Medtech Manufacturers Thrive While Hospitals Shutter—and Patients Suffer. Here’s What Needs to Be Done
Siemens Healthineers debuts 5-second 3D mammogram machine, new mobile MRI
Everything you need to know about artificial wombs
Industry 4.0 metaverse for medtech unlocked
AI Diagnoses Defects in Medical Devices

Share This Article